Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study

Overview of attention for article published in Frontiers in Psychiatry, May 2020

Altmetric Badge

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 15,957 followers.

RT @FrontPsychiatry: New Research: Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatm…

27 May 2020

Reply Repost Favourite

New Research: Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study: Background Major depressive disorder (MDD) constitutes the leading cause of… https://t.co

27 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.